Vitamin D supplementation in patients with COPD: Twitter discussions on behalf of the University of Toronto Respirology and Sleep Journal Club

Affiliations

¹ St Michael's Hospital, Toronto, ON, Canada. Electronic address: AnandA@smh.ca.
² University of Toronto, Toronto, ON, Canada.
³ University of Toronto, Toronto, ON, Canada; Toronto Western Hospital, University Health Network, Toronto, ON, Canada.

Comment

Anju Anand et al. Lancet Respir Med. 2015 Aug.

. 2015 Aug;3(8):e24.

doi: 10.1016/S2213-2600(15)00284-2.

¹ St Michael's Hospital, Toronto, ON, Canada. Electronic address: AnandA@smh.ca.
² University of Toronto, Toronto, ON, Canada.
³ University of Toronto, Toronto, ON, Canada; Toronto Western Hospital, University Health Network, Toronto, ON, Canada.

No abstract available

Comment in

Vitamin D supplementation in patients with COPD: Twitter discussions on behalf of the University of Toronto Respirology and Sleep Journal Club--Authors' Reply.
Martineau AR, Hooper RL. Martineau AR, et al. Lancet Respir Med. 2015 Aug;3(8):e24-5. doi: 10.1016/S2213-2600(15)00285-4. Lancet Respir Med. 2015. PMID: 26282476 No abstract available.

Vitamin D3 supplementation in patients with chronic obstructive pulmonary disease (ViDiCO): a multicentre, double-blind, randomised controlled trial.
Martineau AR, James WY, Hooper RL, Barnes NC, Jolliffe DA, Greiller CL, Islam K, McLaughlin D, Bhowmik A, Timms PM, Rajakulasingam RK, Rowe M, Venton TR, Choudhury AB, Simcock DE, Wilks M, Degun A, Sadique Z, Monteiro WR, Corrigan CJ, Hawrylowicz CM, Griffiths CJ. Martineau AR, et al. Lancet Respir Med. 2015 Feb;3(2):120-130. doi: 10.1016/S2213-2600(14)70255-3. Epub 2014 Dec 2. Lancet Respir Med. 2015. PMID: 25476069 Clinical Trial.